Maxion Therapeutics

Maxion Therapeutics

Biotechnology

Cambridge , England 3,159 followers

Ion channel and GPCR drug discovery using innovative KnotBody technology

About us

Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.

Industry
Biotechnology
Company size
11-50 employees
Headquarters
Cambridge , England
Type
Privately Held
Founded
2020

Locations

  • Primary

    London Road

    Suite 4, The Works, the Unity Campus

    Cambridge , England, GB

    Get directions
  • Babraham Research Campus

    Moneta Building

    Cambridge, CB22 3AT, GB

    Get directions

Employees at Maxion Therapeutics

Updates

Similar pages

Browse jobs

Funding

Maxion Therapeutics 2 total rounds

Last Round

Grant

US$ 2.5M

See more info on crunchbase